Author Schanz, Julie

1 to 20 of 43 Items
  • 2006 Conference Abstract
    ​ ​New and comprehensive cytogenetic prognostication and categorization in MDS.​
    Haase, D.; Germing, U.; Schanz, J.; Pfeilstoecker, M.; Noesslinger, T.; Hildebrandt, B. & Kuendgen, A. et al.​ (2006)
    Blood108(11) ​48th Annual Meeting of the American-Society-of-Hematology​, Orlando, FL.
    Washington​: Amer Soc Hematology.
    Details  WoS 
  • 2006 Conference Abstract
    ​ ​Evidence for an underestimation of the prognostic impact of poor cytogenetics within the IPSS.​
    Haase, D.; Germing, U.; Schanz, J.; Pfeilstoecker, M.; Hildebrandt, B.; Luebbert, M. & Giagounidis, A. A. N. et al.​ (2006)
    Blood108(11) , Orlando, FL.
    Washington​: Amer Soc Hematology.
    Details  WoS 
  • 2007 Conference Abstract
    ​ ​FISH-Analyses of cirulating CD34+cells in MDS-Patients - A suitable method to measure and predict response to 5-azacytidinie.​
    Braulke, F.; Schanz, J.; Steidl, C.; Truemper, L. H. & Haase, D.​ (2007)
    Blood110(11) pp. 727A​-728A. ​49th Annual Meeting of the American-Society-of-Hematology​, Atlanta, GA.
    Washington​: Amer Soc Hematology.
    Details  WoS 
  • 2007 Journal Article
    ​ ​New insights into the prognostic impact of the karyotype in MDS and correlation with subtypes: evidence from a core dataset of 2124 patients​
    Haase, D.; Germing, U.; Schanz, J.; Pfeilstoecker, M.; Noesslinger, T.; Hildebrandt, B. & Kundgen, A. et al.​ (2007) 
    Blood110(13) pp. 4385​-4395​.​ DOI: https://doi.org/10.1182/blood-2007-03-082404 
    Details  DOI  PMID  PMC  WoS 
  • 2008 Conference Abstract
    ​ ​New Prognostic Data on Rare Cytogenetic Abnormalities in MDS: A Collaborative Study of the International Working Group on MDS Cytogenetics.​
    Schanz, J.; Slovak, M. L.; Ohyashiki, K.; Sole, F.; del Mar Mallo, M.; Steidl, C. & Pfeilstoecker, M. et al.​ (2008)
    Blood112(11) pp. 929​-930. ​50th Annual Meeting of the American-Society-of-Hematology​, San Francisco, CA.
    Washington​: Amer Soc Hematology.
    Details  WoS 
  • 2008 Conference Abstract
    ​ ​Analysing Circulating CD34+Cells by FISH Is Representative for the Clone Size in Bone Marrow in MDS Patients Under Different Therapy Modalities.​
    Braulke, F.; Schanz, J.; Truemper, L. H. & Haase, D.​ (2008)
    Blood112(11) pp. 932​-933. ​50th Annual Meeting of the American-Society-of-Hematology​, San Francisco, CA.
    Washington​: Amer Soc Hematology.
    Details  WoS 
  • 2008 Conference Abstract
    ​ ​Prognostic Impact of Additional Chromosomal Aberrations (ACA) to 5q-in Patients with primary Myelodysplastic Syndrome​
    Del Mar Mallo, M.; Cervera, J.; Schanz, J.; Espinet, B.; Such, E.; Luno, E. & Steidl, C. et al.​ (2008)
    Blood112(11) ​50th Annual Meeting of the American-Society-of-Hematology/ASH/ASCO Joint Symposium​, San Francisco, CA.
    Washington​: Amer Soc Hematology.
    Details  WoS 
  • 2009 Conference Abstract
    ​ ​Cytogenetic Risk Features in MDS-Update and Present State.​
    Schanz, J.; Tuechler, H.; Sole, F.; Mallo, M.; Hildebrandt, B.; Slovak, M. L. & Ohyashiki, K. et al.​ (2009)
    Blood114(22) ​51st Annual Meeting of the American-Society-of-Hematology​, New Orleans, LA.
    Washington​: Amer Soc Hematology.
    Details  WoS 
  • 2009 Conference Abstract
    ​ ​Survival, Prognostic Factors, and Rates of Leukemic Transformation in a Multicenter Study of 303 Untreated Patients with MDS and Del(5q)​
    Germing, U.; Lauseker, M.; Hildebrandt, B.; Symeonidis, A.; Cermak, J.; Pfeilstoecker, M. & Noesslinger, T. et al.​ (2009)
    Blood114(22) pp. 390​-391. ​51st Annual Meeting of the American-Society-of-Hematology​, New Orleans, LA.
    Washington​: Amer Soc Hematology.
    Details  WoS 
  • 2009 Journal Article
    ​ ​Amifostine has the potential to induce haematologic responses and decelerate disease progression in individual patients with low- and intermediate-1-risk myelodysplastic syndromes​
    Schanz, J.; Jung, H.; Woermann, B.; Gassmann, W.; Petersen, T.; Hinke, A. & Haase, D.​ (2009) 
    Leukemia Research33(9) pp. 1183​-1188​.​ DOI: https://doi.org/10.1016/j.leukres.2009.03.027 
    Details  DOI  PMID  PMC  WoS 
  • 2010 Journal Article
    ​ ​FISH analysis of circulating CD34+cells as a new tool for genetic monitoring in MDS: Verification of the method and application to 27 MDS patients​
    Braulke, F.; Schanz, J.; Jung, K.; Shirneshan, K.; Schulte, K.; Schuetze, C. & Steffens, R. et al.​ (2010) 
    Leukemia Research34(10) pp. 1296​-1301​.​ DOI: https://doi.org/10.1016/j.leukres.2010.01.010 
    Details  DOI  PMID  PMC  WoS 
  • 2011 Conference Abstract
    ​ ​Genetic Response to Lenalidomide in the Circulating Progenitor Cell Compartment of MDS Cohort. Preliminary Results of the Multicenter German LE-MON-5 Study​
    Shirneshan, K.; Germing, U.; Braulke, F.; Schanz, J.; Platzbecker, U.; Giagounidis, A. A. N. & Nolte, F. et al.​ (2011)
    Blood118(21) ​53rd Annual Meeting and Exposition of the American-Society-of-Hematology (ASH)/Symposium on the Basic Science of Hemostasis and Thrombosis​, San Diego, CA.
    Washington​: Amer Soc Hematology.
    Details  WoS 
  • 2011 Conference Abstract
    ​ ​Proof of Y-Loss As Clonal Abnormality in MDS by Comparative Analysis of CD34+and CD3+Peripheral Blood Cells​
    Ganster, C.; Braulke, F.; Shirneshan, K.; Kaempfe, D.; Platzbecker, U.; Soeling, U. & Bramlage, C. P. et al.​ (2011)
    Blood118(21) pp. 1623​-1624. , San Diego, CA.
    Washington​: Amer Soc Hematology.
    Details  WoS 
  • 2011 Journal Article | 
    ​ ​Treatment of poor-risk myelodysplastic syndromes and acute myeloid leukemia with a combination of 5-azacytidine and valproic acid​
    Kuendgen, A.; Bug, G.; Ottmann, O. G.; Haase, D.; Schanz, J.; Hildebrandt, B. & Nachtkamp, K. et al.​ (2011) 
    Clinical Epigenetics2 pp. 389​-399​.​ DOI: https://doi.org/10.1007/s13148-011-0031-9 
    Details  DOI  PMID  PMC  WoS 
  • 2011 Journal Article
    ​ ​Coalesced Multicentric Analysis of 2,351 Patients With Myelodysplastic Syndromes Indicates an Underestimation of Poor-Risk Cytogenetics of Myelodysplastic Syndromes in the International Prognostic Scoring System​
    Schanz, J.; Steidl, C.; Fonatsch, C.; Pfeilstoecker, M.; Noesslinger, T.; Tuechler, H. & Valent, P. et al.​ (2011) 
    Journal of Clinical Oncology29(15) pp. 1963​-1970​.​ DOI: https://doi.org/10.1200/JCO.2010.28.3978 
    Details  DOI  PMID  PMC  WoS 
  • 2011 Journal Article | Letter Note
    ​ ​Two different del(5q) clones in a patient with myelodysplastic syndrome​
    Braulke, F.; Schanz, J.; Steffens, R.; Liehr, T.; Manvelyan, M.; Chudoba, I. & Haase, D.​ (2011) 
    Leukemia & Lymphoma52(9) pp. 1811​-1814​.​ DOI: https://doi.org/10.3109/10428194.2011.575968 
    Details  DOI  PMID  PMC  WoS 
  • 2012 Conference Abstract
    ​ ​A Comprehensive Genetic Analysis of MDS Patients From Peripheral Blood Combining FISH- and SNP-Array-Analysis​
    Ganster, C.; Shirneshan, K.; Salinas-Riester, G.; Braulke, F.; Schanz, J.; Goetze, K. S. & Bug, G. et al.​ (2012)
    Blood120(21) ​54th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH)​, Atlanta, GA.
    Washington​: Amer Soc Hematology.
    Details  WoS 
  • 2012 Journal Article | Letter Note
    ​ ​Cytogenetic Risk Stratification in Myelodysplastic Syndromes: Are We There Yet? Reply​
    Schanz, J. & Haase, D.​ (2012) 
    Journal of Clinical Oncology30(21) pp. 2704​-2706​.​ DOI: https://doi.org/10.1200/JCO.2012.43.8267 
    Details  DOI  WoS 
  • 2012 Journal Article
    ​ ​Revised International Prognostic Scoring System for Myelodysplastic Syndromes​
    Greenberg, P. L.; Tuechler, H.; Schanz, J.; Sanz, G. F.; Garcia-Manero, G.; Sole, F. & Bennett, J. M. et al.​ (2012) 
    Blood120(12) pp. 2454​-2465​.​ DOI: https://doi.org/10.1182/blood-2012-03-420489 
    Details  DOI  PMID  PMC  WoS 
  • 2012 Journal Article
    ​ ​New Comprehensive Cytogenetic Scoring System for Primary Myelodysplastic Syndromes (MDS) and Oligoblastic Acute Myeloid Leukemia After MDS Derived From an International Database Merge​
    Schanz, J.; Tuechler, H.; Sole, F.; Mallo, M.; Luno, E.; Cervera, J. & Granada, I. et al.​ (2012) 
    Journal of Clinical Oncology30(8) pp. 820​-829​.​ DOI: https://doi.org/10.1200/JCO.2011.35.6394 
    Details  DOI  PMID  PMC  WoS 

Researcher

Sort

issue date

ASC DESC

Items per Page